Google
HYFT — IMMUNOPRECISE ANTIBODIES LTD. (Healthcare >> Biotechnology)
HYFT FAQ
What is HYFT's ROE?
IMMUNOPRECISE ANTIBODIES LTD. reports a Return on Equity (ROE) of -81.34%.
What is HYFT's dividend yield?
IMMUNOPRECISE ANTIBODIES LTD. offers a dividend yield of 0.00%.
What is HYFT's Deepscope Quality Score?
Deepscope rates HYFT's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy HYFT?
Deepscope's AI Timing Score for HYFT is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does HYFT belong to?
IMMUNOPRECISE ANTIBODIES LTD. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 1.68
Price
-0.17
(-9.19%)
Day Change
|
|
|---|
HYFT, the overall quality is not good ( Quality = 31) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 91 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.68 |
| PBV / Sector |
5.61 / 4.63
|
| Earning Per Share | -0.24 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
0.90 M
GREAT
|
| Average 1W Daily Value |
0.90 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:46 |
| Symbol | HYFT |
| Name | IMMUNOPRECISE ANTIBODIES LTD. |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 46.71 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 84.08 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Industrious 823 Congress Ave, Austin, TX, United States, 78701
Phone: 800 620 4187
Website: https://www.mindwalkai.com
Employees: 81
Sector: Healthcare >> Biotechnology
Description: MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
